New Republican Medicaid Proposal

12 February 1996

US Republican state governors have offered a new Medicaid plan to give states more flexibility with block grants and guarantee cover for certain groups of people and benefits. States would have to provide Medicaid for pregnant women and children under six in families with incomes up to 33% above the official poverty level, and services for children aged six to 12 in families below the poverty level. They would also have to provide Medicaid for the disabled, but could set their own definition.

The proposal would guarantee each beneficiary a package of benefits including hospital care, doctors' services, diagnostic tests and childhood immunizations. medicaid would also cover long-term care for low-income people who are disabled or elderly. In contrast to the current scheme, states would receive a fixed amount of federal money to pay for all coverage. They would have to continue spending their own money but the state portion would often be less than is now required.

Chris jennings, special assistant to the President for health policy, says the plan is inadequate because it does not continue the shared federal/state responsibility for Medicaid costs. The GOP suggests that federal government provides extra money to states where the number of recipients rose unexpectedly, but this would cover only some services and some families, not all those who are now entitled, he says. GOP claims that the White House asked Democrat governors to withhold their support so there would be no agreement on medicaid this year have been denied.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight